Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clin (Q52764162)
Jump to navigation
Jump to search
scientific article published on 28 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clin |
scientific article published on 28 November 2017 |
Statements
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ) (English)
D Thaçi
C H Smith
K Reich
A Radin
Q Zhang
B Akinlade
A Gadkari
L Eckert
T Hultsch
Z Chen
G Pirozzi
N M H Graham